Native American patent dispute sets poor pharmaceutical precedent
October 10th, 2017 | by Nick Bell
Embed from Getty Images The drug maker Allergan, which markets the dry-eye drug “Restasis,” recently transferred the patent to a …
October 10th, 2017 | by Nick Bell
Embed from Getty Images The drug maker Allergan, which markets the dry-eye drug “Restasis,” recently transferred the patent to a …
Loading ...